CNS Pharmaceuticals, Inc. (CNSP) › Capital ExpendituresCNS Pharmaceuticals, Inc. (CNSP) — Capital ExpendituresAnnual figures by period end, from SEC filings.2018-12-31: $02019-12-31: $20.1K2020-12-31: $17.9K2021-12-31: $5.7K2022-12-31: $4.4K2023-12-31: $3.9K2024-12-31: $4.2K2025-12-31: $18.2K$18.2K2018-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$18.2K+334.0%2026-03-31From 2025-01-012024-12-31$4.2K+7.4%2026-03-31From 2024-01-012023-12-31$3.9K-11.8%2025-03-31From 2023-01-012022-12-31$4.4K-23.1%2024-04-01From 2022-01-012021-12-31$5.7K-68.0%2023-03-31From 2021-01-012020-12-31$17.9K-10.8%2021-02-12From 2020-01-012019-12-31$20.1K—2021-02-12From 2019-01-012018-12-31$0—2020-03-12From 2018-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)